SHIKARI® Anti-Ixekizumab ELISA (S-ATIXE)

SHIKARI® Anti-Ixekizumab ELISA (S-ATIXE)

Catalog Number:
EK01462304MAT
Mfr. No.:
IXE-QLS-TAL
Price:
Inquiry
  • Size:
    96 tests
    Quantity:
    Add to Cart:
    Add to Cart
      • Overview

        • This kit has been especially developed for the qualitative determination of Ixekizumab in serum and plasma samples.

          The Anti-Ixekizumab (Taltz®) Enzyme-Linked-Immuno Sorbent Assay (ELISA) Kit is intended for the qualitative determination of antibodies to Ixekizumab (Taltz®) in serum and plasma. It is for professional use only. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

          All SHIKARI® ELISA kits are suitable for biosimilar work. All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

          Please contact us at for specific academic pricing.

          More Details

          ELISA Kits for Therapeutic Antibodies and ADAs
      • Properties
        • Details
          Required Volume (µl): 20
          Total Time (min): 140
          Sample: Serum, plasma
          Sample Number: 96
          Detection Limit (ng/mL): + / -
          Spike Recovery (%): -
          Assay Type: Qualitative
          Species Reactivity: Human
          Storage
          1 year shelf life. Store at +4°C. Please refer to protocols.

          * For Research Use Only

      • Applications
        • Application Description
          Enzyme immunoassay for the qualitative determination of specific antibodies to Ixekizumab (Taltz ®) in human serum and plasma.

    Documents

    Instructions for Use

    We Also Recommend

    SHIKARI® Anti-Pertuzumab ELISA (S-ATPER)

    SHIKARI® Anti-Pertuzumab ELISA (S-ATPER)

    SHIKARI® Pertuzumab ELISA (Q-PER)

    SHIKARI® Pertuzumab ELISA (Q-PER)

    SHIKARI® Risankizumab ELISA (S-ATRIS)

    SHIKARI® Risankizumab ELISA (S-ATRIS)